Advanced search×

Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.

Ilham Ratbi, Renata Borcciadi, Asmaa Regragui, Roberto Ravazzolo, and Abdelaziz Sefiani

Clin Rheumatol 29(1):119-21 (2010) PMID 19795179

Fibrodysplasia ossificans progressiva (FOP, MIM 135100) is a rare autosomal dominant disorder characterized by postnatal progressive heterotopic ossification of the connective tissue and congenital malformation of the big toes. Recently, FOP has been associated with a specific mutation of ACVR1, the gene coding for a bone morphogenetic protein type I receptor. We report the case of a Moroccan patient with FOP carrying a rarely occurring mutation of ACVR1 gene.

DOI: 10.1007/s10067-009-1283-z
Version: za2963e q8za1 q8zbd q8zc4 q8zd1 q8ze9 q8zff q8zg5
Buy PDF

Similar articles you may find interesting…

  1. A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients.
    Sergio S Crovella, Ludovica L Segat, ... Paolo P Gasparini

    Clin Chem Lab Med 49(1):49-54 (2011) PMID 21077791

    We attempted to replicate previous findings and verify the possible association between three single nucleotide polymorphisms (SNPs c.-52G>A, c.-44C>G and c.-20G>A) in the 5' untranslated region (5' UTR) of the β defensin 1 (DEFB1) gene and the CF pulmonary phenotype....
    Buy PDF
  2. Fluid resuscitation preserves cardiac output but cannot prevent organ damage in a porcine model during 24 h of intraabdominal hypertension.
    Alexander A Schachtrupp, Gilbert G Lawong, ... Volker V Schumpelick

    Shock 24(2):153-8 (2005) PMID 16044086

    We examined 12 domestic pigs with a mean body weight of 48 kg. We used a CO2 pneumoperitoneum to increase the IAP to 30 mmHg in 6 animals, and the others served as control group. The investigation period was 24 h. In addition to a standard infusion regimen, Ringer's solution was infused to maintain...
    Buy PDF
  3. Adjuvant chemotherapy for resected non-small-cell lung cancer.
    Benjamin B Solomon, John D JD Mitchell, and Paul A PA Bunn

    Oncology (Wi... 19(13):1685-97; discussion 1698-700, 1705 (2005) PMID 16425522

    Because of the high rate of distant disease recurrence, the 5-year survival of patients who have undergone complete surgical resection of localized non-small-cell lung cancer (NSCLC) is approximately 50%. Initial results from early studies of adjuvant postoperative chemotherapy reported an adverse e...
    Buy PDF